UPA Magtidelira PEN 33mg NEW HYBRID

UPA Magtidelira PEN 33mg NEW HYBRID

R 2,100.00
R 2,100.00
Skip to product information
UPA Magtidelira PEN 33mg NEW HYBRID
  • UPA Magtidelira PEN 33mg NEW HYBRID
  • UPA Magtidelira PEN 33mg NEW HYBRID
UPA Magtidelira PEN 33mg NEW HYBRID

UPA Magtidelira PEN 33mg NEW HYBRID

R 2,100.00
R 2,100.00
Shipping calculated at checkout.

UPA Maglira 5mg Pen

Clinically Proven Liraglutide for Weight Loss & Blood Sugar Control

The UPA Maglira 5mg Pen is a premium, prefilled injectable designed to help regulate appetite, manage blood sugar, and support steady, sustainable fat loss. Powered by Liraglutide, a clinically proven GLP-1 analogue, Maglira works by mimicking the body’s natural satiety hormone - reducing hunger, slowing gastric emptying, and promoting long-term weight management without extreme diets or routines.
UPA Maglira is a high-quality Liraglutide-based injectable solution developed for weight loss and appetite control.

Slower gastric emptying to reduce calorie intake. Liraglutide is now available in a cost-effective 5mg prefilled pen from UPA. Pure, potent and easy to use. Pre-filled — no vials or syringes needed. Precision dosing with a smooth dial-up mechanism. Pharmaceutical-grade formulation designed for daily use for effective weight or diabetes management Experience professional-grade GLP-1 support with UPA Maglira — your reliable partner in achieving consistent, healthy results.